Stock News and Filings Feed


Add ATT
to your dashboard

Abattis Prepares for Growth in Extracts -- CFN Media

2017-09-20 marketwired
SEATTLE, WA--(Marketwired - Sep 20, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing Abattis Bioceuticals Corp. (CSE: ATT) (ATT.CN) (CNSX: ATT) (OTCQB: ATTBF) and why its proprietary extraction technology represents an important breakthrough that shouldn't be ignored. While many licensed producers are focused on expanding capacity, the best opportunities may be those that can add value for existing licensed producers. (4-0)

It's Easy Being Green

2017-05-16 seekingalpha
Would you have done like everyone else and ignored it? Everyone did. There were no offers. None.

Abattis Announces the Official Launch of Northern Vine Laboratory

2017-05-03 accesswire
VANCOUVER, BC / ACCESSWIRE / May 3, 2017 / Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the "Company" or "Abattis") is pleased to announce that its subsidiary, Northern Vine Canada Inc. ("Northern Vine"), has officially launched its flagship laboratory, having completed its first successful test analysis.

Abattis Signs Exclusive Distribution Agreement for Proprietary Extraction Technology

2017-04-26 accesswire
VANCOUVER, BC / ACCESSWIRE / April 26, 2017 / Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the "Company" or "Abattis") is pleased to announce that it has signed an exclusive distribution agreement, effective April 20, 2017 (the "Agreement"), with Suzhou Raybot Material Tech Corp. ("Raybot"). The Agreement allows Abattis to use Raybot's proprietary extraction technology and to exclusively sell the extraction equipment and services.

Abattis Bioceuticals Announces New CEO

2017-04-10 accesswire
VANCOUVER, BC / ACCESSWIRE / April 10, 2017 / Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the "Company" or "Abattis") is pleased to announce the appointment of Robert Abenante as President and Chief Executive Officer of the Company.

Abattis Bioceuticals Gets Added to the Marijuana Index by MJIC

2017-04-06 accesswire
VANCOUVER, BC / ACCESSWIRE / April 6, 2017 / Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the "Company" or "Abattis"), is pleased to announce it has officially been added to The Marijuana Index, within the Biotechnology sector.

Canada's Plans for Near-term Legalization Puts Testing into Focus -- CFN Media

2017-04-04 marketwired
SEATTLE, WA--(Marketwired - Apr 4, 2017) - CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing the planned legalization of cannabis in Canada, the growing and urgent need for testing in both the existing and upcoming legal cannabis markets, and Abattis Bioceuticals Inc.'s (CSE: ATT) (OTCQB: ATTBF) role via the company's federally-licensed subsidiary, Northern Vine Labs.

Abattis: Legislation to Legalize Marijuana in Canada is Being Announced Next Month

2017-03-27 accesswire
VANCOUVER, BC / ACCESSWIRE / March 27, 2017 / Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the "Company" or "Abattis"), and its subsidiary, Northern Vine Labs, is anticipating the Liberal government's upcoming announcement, next month (the week of April 10th), on legislation that will legalize recreational marijuana use across Canada by July 1, 2018.

Abattis Welcomes Dr. David Galvez as Science Advisor to Northern Vine

2017-03-20 accesswire
VANCOUVER, BC / ACCESSWIRE / March 20, 2017 / Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the "Company" or "Abattis") is pleased to announce that Dr. David Galvez, PhD, will be joining the team to lead Northern Vine's Science Advisory efforts.

Abattis Team Positions for Next Stage of Growth

2017-03-13 accesswire
VANCOUVER, BC / ACCESSWIRE / March 13, 2017 / Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the "Company" or "Abattis") is pleased to announce the addition of Jaclyn Thomson, PhD, to our senior management team at Northern Vine Labs, and the appointment of Rene David to the Abattis Board of Directors. As the construction and buildout of Northern Vine Labs continues, more key management hires and appointments will accompany this next stage of growth.

CSE: 2017-0301 - Reinstatement - Abattis Bioceuticals Corp. (ATT)

2017-03-03 marketwired
TORONTO, ONTARIO--(Marketwired - March 3, 2017) - Effective immediately the shares of Abattis Bioceuticals Corp. will be reinstated for trading.

Abattis Completes Audit and Prepares to Launch Northern Vine Labs

2017-02-24 accesswire
VANCOUVER, BC / ACCESSWIRE / February 24, 2017 / Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CNSX: ATT) ("ATT" or the "Company") is pleased to announce the completion of their annual audit. The delay in filing was due to an eventful year with new programs coming online and an aggressive strategy to cut non-core assets resulting in prolonged consolidations and subsequent review.

Agritek Holdings, Inc. Announces Plans For Additional Cultivation Property With Licenses In Colorado On Heels of Receiving Listing In First Proposed Cannabis Exchange Fund (ETF)

2017-02-23 marketwired
LOS ANGELES, CA--(Marketwired - Feb 23, 2017) - Agritek Holdings, Inc. (OTC PINK: AGTK), a leader in compassionate care technology and agricultural solutions for the recreational cannabis industry, today announced that the Company has entered into negotiations to purchase an additional thirty-five (35) acre property located in Pueblo county which has already been approved and received licenses for cultivation.

Abattis Addresses Key Shortcomings in Canada's Cannabis Industry -- CFN Media

2017-02-09 marketwired
SEATTLE, WA--(Marketwired - Feb 9, 2017) - CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing Abattis Bioceuticals Inc. (CSE: AT) (OTC PINK: ATTBF) and the role the company's subsidiary, Northern Vine Labs, and similar labs play in the burgeoning Canadian legal cannabis industry.

CSE: 2017-0204 - Suspension - Abattis Bioceuticals Corp. (ATT)

2017-02-06 marketwired
TORONTO, ONTARIO--(Marketwired - Feb. 6, 2017) - Abattis Bioceuticals Corp. is in default of CSE requirements. Effective immediately, Abattis Bioceuticals will be suspended pursuant to CSE Policy 3. The suspension is considered a Regulatory Halt as defined in National Instrument 23-101 Trading Rules. A cease trade order has been issued by the British Columbia Securities Commission and the Ontario Securities Commission.

Abattis Audit Update

2017-02-03 accesswire
VANCOUVER, BC / ACCESSWIRE / February 3, 2017 / Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) ("ATT" or the "Company") announces that it is completing work on its audit and has been working with its auditor to complete the process in order to have it ready to file as soon as possible. It is anticipated that this delay will result in a temporary issuer cease trade order, which Abattis shall seek to remove as soon as the audited financial statements are filed.

Abattis Explores Diversifying with a Strategic Acquisition -- CFN Media

2017-01-19 marketwired
SEATTLE, WA--(Marketwired - Jan 19, 2017) -  CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing Abattis Bioceuticals Corp. (OTC PINK: ATTBF) (CNSX: ATT), a specialty agricultural technology firm focused on the legal cannabis industry. The company recently commissioned an independent valuation on Green Nature Health Care Products Inc.

Abattis Announces an Independent Valuation on Green Nature Health Care Products

2017-01-16 accesswire
VANCOUVER, BC / ACCESSWIRE / January 16, 2017 / Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CNSX: ATT) (the "Company" or "Abattis") provides an update to its shareholders.

Abattis Bioceuticals (ATTBF) Northern Vine Labs and the New Canadian Rules -- CFN Media

2017-01-05 marketwired
SEATTLE, WA--(Marketwired - Jan 5, 2017) - CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article covering Abattis Bioceuticals Corp.'s (OTCQB: ATTBF) (CSE: ATT) Northern Vine Labs subsidiary and the effect newly proposed rules in Canada could have on the business.

Abattis Issues Common Shares

2016-12-17 accesswire
VANCOUVER, BC / ACCESSWIRE / December 16, 2016 / Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CNSX: ATT) (the "Company" or "Abattis"), announces that today the Company issued 534,389 common shares as compensation for services to consultants, directors and employees of the Company for the month ended November 30, 2016 and in respect of prior months outstanding, no legend was required on any of the issued shares.

Abattis Provides Corporate Update

2016-12-16 accesswire
VANCOUVER, BC / December 16, 2016 / Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CNSX: ATT) (the "Company" or "Abattis") provides an update to its shareholder.

Abattis Announced Private Placement Agreement of Up To $5,000,000

2016-12-08 accesswire
VANCOUVER, BC / ACCESSWIRE / December 8, 2016 / Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the "Company" or "Abattis"), is pleased to announce that the Company entered into a non-binding agreement for a draw-down equity facility of up to $5,000,000 CAD. The agreement provides for equity private placement offerings (the "Offerings"), to be conducted between Abattis and Alumina Partners (Ontario) Ltd.